Tianjin Ringpu Bio-technology Co., Ltd. Class A · SZSE:300119

Tianjin Ringpu Bio-technology Co., Ltd. Class A shareholders

Tianjin Ringpu Bio-technology Co., Ltd. Class A on 6ix: holders from US fund reports. Largest: Emerging Markets Core Equity 2 Portfolio, Dimensional Emerging Markets Value Fund and The Emerging Markets Small Cap Series. Each with its filing.

Shareholders

HolderSharesValueChangeAs of
Emerging Markets Core Equity 2 Portfolio255KUS$644K−65,500Jul 31, 2026
Dimensional Emerging Markets Value Fund134KUS$338K+94,400Jul 31, 2026
The Emerging Markets Small Cap Series81,135US$204KNo changeJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF60,500US$152KNo changeJul 31, 2026
Dimensional Emerging Core Equity Market ETF48,500US$122K+16,400Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF30,100US$75,858+7,800Jul 31, 2026
Emerging Markets Social Core Equity Portfolio18,500US$46,620No changeJul 31, 2026
World ex U.S. Core Equity Portfolio17,400US$43,848No changeJul 31, 2026
Dimensional Emerging Markets Value ETF11,300US$28,478−9,100Jul 31, 2026
Emerging Markets Targeted Value Portfolio10,400US$26,208No changeJul 31, 2026
World ex U.S. Targeted Value Portfolio8,400US$21,168No changeJul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio8,200US$20,664No changeJul 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF1,100US$2,772No changeJul 31, 2026

Tianjin Ringpu Bio-technology Co., Ltd. Class A insider trades